-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE REACHES IMPORTANT CLINICAL MILESTONE: 20 PARTICIPANTS NOW TREATED IN ONGOING PHASE I/IIA TRIAL OF CMND-100 FOR ALCOHOL USE DISORDER

Reuters·05/12/2026 12:41:00

Please log in to view news